Sanofi showcases eczema data ahead of EU decisionDupixent predicted to be blockbuster for Sanofi Share XSanofi showcases eczema data ahead of EU decisionhttps://pharmaphorum.com/news/dupixent-data-sanofi-ahead-eu-decision/
Pfizer’s eczema drug Eucrisa approvedPfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of Share XPfizer’s eczema drug Eucrisa approvedhttps://pharmaphorum.com/news/pfizers-eczema-drug-eucrisa-approved/